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J-G, Yoon J-H. Expression and localization of surfactant proteins
in human nasal epithelium. Am J Physiol Lung Cell Mol Physiol
292: L879–L884, 2007. First published January 5, 2007;
doi:10.1152/ajplung.00156.2006.—Surfactant proteins (SPs), desig-
nated SP-A, SP-B, SP-C, and SP-D, play an important role in
surfactant metabolism and host defense mechanisms in the lung. This
study investigates expression of the different SP types in human nasal
mucosa and cultured normal human nasal epithelial (NHNE) cells and
whether the expression of SP mRNA is influenced by the degree of
mucociliary differentiation. RT-PCR was performed with mRNA
from cultured NHNE cells and nasal mucosa. Immunohistochemical
staining for SPs was performed on nasal mucosa specimens. Western
blot analysis was performed on cell lysates from cultured NHNE cells.
SP-A2, SP-B, and SP-D mRNAs were expressed in normal NHNE
cells and human nasal mucosa. SPs were localized in ciliated cells of
the surface epithelium and serous acini of the submucosal glands.
SP-A, SP-B, and SP-D proteins were expressed in cultured NHNE
cells. The degree of mucociliary differentiation influenced expression
of the SP gene. We demonstrate that SP-A, SP-B, and SP-D are
expressed in human nasal mucosa and cultured NHNE cells. Further
study of the functional role of SPs in the upper airway is required.
surfactant proteins A, B, and D
SURFACTANT PROTEINS (SPs) are a complex mixture of lipids and
proteins that play an important role in host defense mecha-
nisms as well as surfactant metabolism. The surfactant-associ-
ated proteins are designated SP-A, SP-B, SP-C, and SP-D (9).
SP-A and SP-D are sialoglycoproteins and members of the
collectin family (7, 8, 9, 16). They are hydrophilic proteins and
are considered to have a critical role in innate immunity (9, 16).
SP-A and SP-D bind a variety of bacterial, viral, and fungal
pathogens and are important in the initial phases of host
defense (16). Human SP-A is encoded by two genes, SP-A1
and SP-A2 (3). In contrast, SP-B and SP-C are very hydropho-
bic proteins and are thought to be principally involved in
surfactant function as well as the packaging and organizing of
phospholipids (15). SPs were originally considered to be lung
specific and to only be involved in breathing (1). The obser-
vation that a phospholipid-rich surface lining is not unique to
the lung alveoli suggested that other organs might also express
SPs. To date, the expression of SPs has been detected in the
gastric and intestinal mucosa (1, 7), joints (1), peritoneum (1),
pericardium (1, 7), skin (12), middle ear (2, 11), Eustachian
tubes (13, 14), and maxillary sinus mucosa (2). In addition,
surfactant-like materials have been identified in the tongue
papillae and oral epithelium (1). However, the presence of SPs
in human nasal mucosa has not been determined.
Recently, Goss et al. (3) reported the detection of SP-A1 and
SP-A2 mRNA in adult human lung tissue and cultured human
fetal lung explants. SP-A2 mRNA, but not SP-A1 mRNA, was
also detected in human fetal trachea and bronchi. This same
report further indicated that SP-A1 was expressed in the lung
tissue including alveoli, but not in the trachea and bronchi,
suggesting that the expression of certain surfactant genes could
be different between the upper and lower airways. Gene
expression could be influenced by the degree of mucociliary
differentiation of the airway epithelium, which is greater in the
upper airway.
The aims of this study were to determine the type of
surfactant mRNA and proteins expressed in human nasal mu-
cosa and cultured normal human nasal epithelial (NHNE) cells,
to localize the SPs in human nasal mucosa, and to determine
whether surfactant gene expression is influenced by the degree
of mucociliary differentiation in human nasal epithelial cells.
MATERIALS AND METHODS
Materials. Inferior turbinate mucosa specimens were obtained from
five patients who had undergone septoplasties without histories of
chronic sinusitis, chronic asthma, aspirin sensitivity, or cystic fibrosis,
and who had negative allergic skin-prick test results. Patients had not
received an antibiotic regimen, oral steroids, or intranasal medication
during the 3 mo before the study. Lung parenchymal specimens,
including the terminal bronchi, were obtained from a lung cancer
patient who had undergone a pneumonectomy. Informed consent was
obtained from all patients, and the local Ethical Committee approved
the use of all specimens. SP-A and SP-C were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). SP-B and SP-D antibodies
were purchased from Abcam (Cambridge, UK).
Cell cultures. The epithelial cells from the nasal turbinate mucosa
were isolated by treatment with 1% pronase (Type XIV protease;
Sigma Chemical, St. Louis, MO) in a 1:1 mixture of DMEM/Ham’s
F-12 supplemented with penicillin G sodium (50 IU/ml) and strepto-
mycin sulfate (50 g/ml) for 18–20 h at 4°C. To remove fibroblasts,
endothelial cells and myoepithelial cells by differential attachment to
plastic, isolated cells were placed in a plastic dish and cultured for 1 h
at 37°C. The nonadherent cells were mostly epithelial cells. Sus-
pended epithelial cells were seeded at 3  104 cells/dish (500
cells/square cm) into 10-cm plastic tissue culture dishes. The culture
medium used was bronchial epithelial growth medium (BEGM; Clo-
netics) containing all the supplements previously described (17). The
culture medium was changed on day 1 after seeding and every other
day thereafter until the cultures reached 50–60% confluency (6–7
days), at which time they were dissociated with 0.25% trypsin/EDTA
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(17). In brief, passage 2 NHNE cells (2  105 cells/culture) were
seeded in 0.5 ml of culture medium on Transwell clear culture inserts
(24.5 mm, 0.45-m pore size; Costar, Cambridge, MA). Cells were
cultured in a 1:1 mixture of BEGM and DMEM containing all the
supplements previously described (17). Cultures were grown while
submerged for the first 9 days, during which time the culture medium
was changed on day 1 and every other day thereafter. The air-liquid
interface was created on day 9 by removing the apical medium and
feeding the cultures only from the basal compartment. Culture me-
dium was changed daily after interface creation. The cells were
exposed to all-trans retinoic acid (107 mol/l) from the start of the
culture to 28 days after confluence. To investigate differentiation in
the cultured cells, total RNA was isolated from whole cells on 2, 7, 14,
and 28 days after confluence using TRIzol according to the manufac-
turer’s recommendations. Cell lysates were collected 2, 7, 14, and 28
days after confluence to investigate the presence of the proteins.
Immunohistochemistry. Paraffin-embedded sections (4 mm) were
deparaffinized and rehydrated. After being washed and consecutive
incubation with blocking medium, sections were incubated with
primary antibodies overnight at 4°C (rabbit polyclonal SP-A anti-
serum, mouse monoclonal SP-D antiserum diluted 1:100, and mouse
monoclonal SP-B antiserum diluted 1:50 in the dilution solution). The
sections were then washed repeatedly in PBS. The reaction between
the antigen and antibodies was detected using peroxidase-conjugated
anti-rabbit secondary antibodies. Negative controls were stained with
purified rabbit nonimmune IgG at the same concentration as the
primary antibody.
RT-PCR. Oligonucleotide primers were designed according to
published sequences and are shown in Table 1. Oligonucleotide
amplimers for 2-microglobulin (2M), used as a control gene for
RT-PCR, were purchased from Clontech Laboratories (Palo Alto, CA)
and generated a 335-bp PCR fragment. RT-PCR was performed.
Three micrograms of RNA were used for the RT reaction, and then
1 l of cDNA was used for PCR with a Perkin-Elmer Cetus DNA
Thermal Cycler (Perkin-Elmer, Norwalk, CT) according to the man-
ufacturer’s recommendations. The same amount of RNA and cDNA
was used for the lung, nasal turbinate, and NHNE cell samples.
Comparative kinetic analysis was used to compare mRNA levels for
each set of culture conditions. PCR products were separated by
electrophoresis on a 2% Seakem agarose gel (FMC, Rockland, ME)
containing 50 ng/ml ethidium bromide and photographed with Po-
laroid Type 55 film. The negatives were scanned on a Molecular
Dynamics Densitometer (Sunnyvale, CA), and the signal was ana-
lyzed using ImageQuant software. To verify that the amplified prod-
ucts were from mRNA and not genomic DNA contamination, nega-
tive controls were performed omitting the reverse transcriptase; no
PCR products were observed. Specific amplification of all target genes
was confirmed by the sequencing of PCR products (dsDNA Cycle
Sequencing System; GIBCO-BRL, Rockville, MD).
Fig. 1. Expression of surfactant protein (SP) mRNA in human nasal
mucosa and cultured normal human nasal epithelial (NHNE) cells. Three
micrograms of RNA and 1 l of cDNA were used for all 3 samples. SP-A2,
SP-B, and SP-D mRNA was expressed in human nasal mucosa and cultured
NHNE cells. All 5 types of SP were expressed in human lung tissue used
as a positive control. Shown is representative of 4 separate experiments.
2M, 2-microglobulin.
Table 1. RT-PCR primers and reaction conditions
Target Genes Primer Sequences
Annealing
Temperature, °C Cycles Size, bp
SP-A1 F-GTG TGG GTC GCT GAT TTC TT 62 32 194
R-TCC AAC ACA AAC GTC CCT TCA
SP-A2 F-CAG TAC CGG CCA AGC ATA AT 62 32 184
R-CAT GTC AGT CAC AGG GTT GG
SP-B F-GGC CCT TGT CTG TCT AGC TC 62 32 176
R-CTT CAA CCC CCT GTC CTG TA
SP-C F-CTG GTT ACC ACT GCC ACC TT 55 32 179
R-CTG GCC CAG CTT AGA CGT AG
SP-D F-AAC CAT TTA CGG AGG CAC AG 55 32 228
R-CTC TCC TGT GGG GTA GGT GA
Cornifin- F-CAT TCT GTC TCC CCC AAA AA 60 29 172
R-ATG GGG GTA TAA GGG AGC TG
MUC5AC F-TCC GGC TCC ATC TTC TCC 60 35 680
R-ACT TGG GCA CTG GTG CTG
MUC8 F-ACA GGG TTT CTC CTC ATT G 55 35 239
R-CGT TTA TTC CAG CAC TGT TC
2-microglobulin F-TCG CGC TAC TCT CTC TTT CTG G 55 28 360
R-GCT TAC ATG TCT CGA TCC CAC TTA A
SP, surfactant protein.
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Western blot analysis. Cells were lysed with 2 lysis buffer (250
mM Tris HCl, pH 6.5, 2% SDS, 4% 2-mercaptoethanol, 0.02%
bromphenol blue, 10% glycerol). Equal amounts (50 g/25 l) of
whole cell lysates were resolved using 10% SDS-polyacrylamide gel
electrophoresis and transferred to a polyvinylidene difluoride mem-
brane (Millipore, Bedford, MA). Membranes were blocked with 5%
skimmed milk in Tris-buffered saline (TBS; 50 mM Tris HCl, pH 7.5,
150 mM NaCl) for 2 h at room temperature. The blot was then
incubated overnight with primary antibody (rabbit polyclonal SP-A
and SP-C antisera, mouse monoclonal SP-D antiserum diluted
1:1,000, and mouse monoclonal SP-B antiserum diluted 1:100 in the
dilution solution) in 0.5% Tween 20 in TBS (TTBS). After being
washed with TTBS, the blot was further incubated for 45 min at room
temperature with anti-rabbit or anti-mouse antibody (Cell Signaling,
Beverly, MA) in TTBS. Blots were visualized using the ECL system
(Amersham-Pharmacia, Piscataway, NJ).
RESULTS
Expression of SP mRNA in human nasal mucosa and cul-
tured NHNE cells. SP-A2, SP-B, and SP-D mRNAs were
expressed in NHNE cells and inferior turbinate mucosa, but
SP-A1 and SP-C mRNA were not. In contrast, all types of SP
mRNA were expressed in the human lung tissue used as a
positive control (Fig. 1). These results demonstrate that expres-
sion of SP mRNAs differs between the upper and the lower
human airway mucosa. On the basis of these results, we
Fig. 2. Localization of SP-A in human nasal
mucosa and cultured NHNE cells in immu-
nohistochemical staining. A and C: SP-A
was expressed in the cytoplasm of ciliated
epithelial cells (arrowhead) and in serous
acini (arrow) of the submucosal gland of
human nasal mucosa. B and D: negative
controls were stained with purified rabbit
nonimmune IgG antibody.
Fig. 3. Localization of SP-B in human nasal
mucosa and cultured NHNE cells in immuno-
histochemical staining. A and C: SP-B was
expressed in the cytoplasm of ciliated epi-
thelial cells (arrow head) and in serous acini
(arrow) of the submucosal gland of human
nasal mucosa. B and D: negative controls
were stained with purified rabbit nonimmune
IgG antibody.
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selected SP-A2, SP-B, and SP-D for all subsequent experi-
ments.
Localization of SP proteins in human nasal mucosa. We
investigated the localization of SP-A, SP-B, and SP-D proteins
in human nasal mucosa. All three SP proteins showed the same
pattern of expression; they were expressed in the ciliated cells
of the surface epithelium but not the goblet cells. In the
submucosal glands, the proteins were expressed in serous acini
but not in mucous acini (Figs. 2, 3, 4). Some inflammatory cells
were also stained. Negative controls using purified IgG showed
no reactivity.
Expression of SP proteins in cultured NHNE cells. We next
examined the expression of SP-A2, SP-B, and SP-D proteins in
NHNE cells to confirm the RT-PCR data showing the presence
of their mRNAs. Western immunoblot analysis revealed the
characteristic molecular weight profiles of SP-A2 (35 kDa),
SP-B (10 kDa), and SP-D (43 kDa) proteins. SP-C protein
(4–11 kDa) was identified in lung lysate but not in cultured
NHNE cells. These results indicate that SP-A2, SP-B, and
SP-D proteins are expressed in cultured NHNE cells (Fig. 5).
Induction of mucociliary differentiation of human nasal
epithelial cells. Differentiation of mucociliary epithelium was
induced by the addition of retinoic acid to the culture medium.
Histological examination showed that the epithelium was
monolayered on the day of confluence. Cuboidal epithelium
was seen on the 7th day after confluence and columnar epithe-
lium with some cilia on the 14th day after confluence. By the
28th day after confluence, columnar epithelium with many cilia
could be observed (Fig. 6A). Expression of the MUC5AC gene,
a marker of mucous differentiation (18), and MUC8, a ciliated
cell marker (4), increased with time. In contrast, expression of
cornifin-, a marker of squamous cell differentiation (5), de-
creased (Fig. 6B). These results show that the epithelial cells
differentiated into mucociliary epithelium in our in vitro cul-
Fig. 4. Localization of SP-D in human nasal
mucosa and cultured NHNE cells in immu-
nohistochemical staining. A and C: SP-D
was expressed in the cytoplasm of ciliated
epithelial cells (arrow head) and in serous
acini (arrow) of the submucosal gland of
human nasal mucosa. B and D: negative
controls were stained with purified rabbit
nonimmune IgG antibody.
Fig. 5. Expression of SPs in cultured NHNE cells. Fifty micrograms of proteins were used for the lung sample and NHNE cells. SP-A, SP-B, and SP-D were
detected in cultured NHNE cells by Western blot analysis, but SP-C was not. However, all 4 types of SP were expressed in the human lung tissue that was used
as a positive control. Shown is representative of 4 separate experiments.
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ture system. The typical morphology of human airway epithe-
lium is mucociliary epithelium.
SP mRNA expression as a function of mucociliary differen-
tiation in NHNE cells. We wanted to examine whether the level
of SP-A2, SP-B, and SP-D gene expression is influenced by the
degree of mucociliary differentiation in human primary nasal
epithelial cells. RT-PCR analysis revealed that SP-A2, SP-B,
and SP-D gene expression increased as a function of mucocili-
ary differentiation (Fig. 7, A and B). These results indicate that
the degree of mucociliary differentiation influences the expres-
sion of SP-A2, SP-B, and SP-D mRNA in cultured human
nasal epithelial cells. The expression of SP-A and SP-D pro-
teins also increased during cell differentiation in a pattern
similar to mRNA expression. SP-B, however, was not in-
creased (Fig. 7C).
DISCUSSION
SPs are lipoprotein complexes composed of 90% phospho-
lipids and 10% protein that are synthesized and secreted by
alveolar type II epithelial cells and airway Clara cells into the
thin liquid layer that lines the epithelium. Once in the extra-
cellular space, SPs perform two distinct functions: they reduce
surface tension at the air-liquid interface of the lung and they
play a role in host defense against infection and inflammation
(10, 16).
In this study, we found that all types of SP mRNA were
expressed in human lung tissue, but only three types, SP-A2,
SP-B, and SP-D, were expressed in human nasal mucosa.
These results suggest that the pattern of SP mRNA expression
is different between the upper and lower airways. SP-A and
SP-D proteins and their transcripts have been found in a
number of tissues besides airway mucosa, including rat and
human gastric and intestinal mucosa, mesothelial tissues (mes-
entery, peritoneum, and pleura), synovial cells, adult rabbit
Eustachian tube and sinus, and possibly human salivary glands,
pancreas, and urinary tract (1). Initially, SP-B and SP-C ap-
peared to be expressed in lung epithelium only (1), but
Paananen et al. (14) have reported expression of SP-B mRNA
Fig. 6. Induction of mucociliary differentiation of human nasal
epithelial cells. A: time-dependent changes in the histology of
cultured NHNE cells. Cross-sections of intact culture were
stained with hematoxylin and eosin. As culture duration in-
creased, a multilayer epithelium was observed, and cilia (arrow)
could be seen. B: there was greater expression of MUC5AC, a
mucous differentiation marker, and MUC8, a ciliary differenti-
ation marker, whereas expression of cornifin-, a squamous
epithelial marker, declined with increased culture duration.
With increasing time, cultured NHNE cells were induced to
differentiate into mucociliary epithelial cells. Shown is repre-
sentative of 4 separate experiments.
Fig. 7. Expression of SP genes and proteins as
a function of mucociliary differentiation. A:
densitometric analysis of PCR data obtained
from 4 separate experiments. Data are ex-
pressed as means  SE. B: SP-A2, SP-B, and
SP-D gene expression increased at 7, 14, and
28 days after confluence. C: SP-A and SP-D
protein expression increased with a parallel
pattern, but SP-B levels did not change. Shown
is representative of 4 separate experiments.
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in extrapulmonary organs, especially the porcine Eustachian
tube. These data suggest that surfactant mRNAs may be
differentially expressed depending on organ type.
Concerning the localization of SPs, we found that SP-A2,
SP-B, and SP-D were all expressed in the ciliated cells of the
surface epithelium and serous acini of the submucosal gland in
human nasal mucosa (Figs. 2, 3, 4). This result is in accordance
with previous reports that SPs are expressed in surface epithe-
lium and serous cells of submucosal glands (4, 6, 8, 13).
Interestingly, SP-D has also been identified in mucus-secreting
epithelium near the cardioesophageal junction (1). This dis-
crepancy suggests that the cells secreting certain SPs may be
different according to organ type.
We examined whether surfactant gene expression is influ-
enced by the degree of mucociliary differentiation in human
nasal epithelial cells. In the presence of retinoic acid, cultured
NHNE cells were differentiated into mucociliary epithelium
(17). Histological and molecular characterization of differen-
tiated cells at the indicated time points confirmed that muco-
ciliary differentiation occurred in our culture system. As mu-
cociliary differentiation progressed, expression of MUC5AC, a
mucous cell marker, and MUC8, a ciliated cell marker, in-
creased. Expression of cornifin-, a squamous cell marker,
decreased. Expression of SP-A2, SP-B, and SP-D increased as
a function of mucociliary differentiation. These results suggest
that the level of SP increases as the epithelial cells differentiate
into mucociliary epithelium. The expression of SP-A and SP-D
proteins increased during cell differentiation to mucociliary
epithelium. However, SP-B showed no change in four separate
repeat experiments. Although we did not determine why SP-B
expression did not increase, we postulate that SP-B protein is
regulated at a posttranscriptional level.
In conclusion, we found that SP-A2, SP-B, and SP-D genes
are expressed in the ciliated epithelial cells and serous acini of
the submucosal glands of the human nasal mucosa. In addition,
expression of these genes was influenced by the degree of
mucociliary differentiation. Further studies are required to
clarify the functions of SPs in human nasal mucosa.
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